SIC
CRDF icon

SJS Investment Consulting’s Cardiff Oncology CRDF Stock Holding History

SJS Investment Consulting’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82 Buy
+63
New +$100 ﹤0.01% 2643

Other funds holding CRDF

AC
Avestar Capital New York $1.79B AUM 33.8% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
PRTG
Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
BEAM
Baker Ellis Asset Management Vancouver, Washington $964M AUM 39.24% 1-Year Est. Return
CAWM
Capital Advisors Wealth Management Yakima, Washington $851M AUM 22.16% 1-Year Est. Return
GIA
Gladstone Institutional Advisory Palm Beach Gardens, Florida $3.16B AUM 29.04% 1-Year Est. Return
SA
Scarborough Advisors Annapolis, Maryland $871M AUM 21.96% 1-Year Est. Return

SJS Investment Consulting's CRDF Position: Q2 2026 in Review

SJS Investment Consulting opened a new position in Cardiff Oncology (CRDF) in Q2 2026: 63 shares worth $82. The stake represents ﹤0.01% of the portfolio and ranks #2643 among its holdings.

22 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • SJS Investment Consulting held 63 shares of Cardiff Oncology worth $82 as of Q2 2026.
  • Cardiff Oncology was a new SJS Investment Consulting position in Q2 2026.
  • Cardiff Oncology made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2643 holding.
  • 22 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.